DNAPrint Genomics (DNAG) Stock Price, News & Analysis

Company Overview

DNAPrint Genomics, Inc. was a biotechnology company focused on applying genetic analysis to ancestry, identity, and forensic investigations. The company developed DNA-based testing products intended to estimate biogeographical ancestry and provide information about an individual’s genetic background.

Its offerings included ancestry testing services marketed to consumers and investigative tools such as DNAWitness, a forensic analysis platform designed to help infer physical characteristics and ancestral background from biological evidence. The company also pursued applications of genomics in areas including personalized medicine and pharmacogenomics.

DNAPrint Genomics was based in Sarasota, Florida, and primarily served the U.S. consumer, law-enforcement, and forensic markets. Tony Frudakis was associated with the company as a founder and chief executive. Public information about the company’s current operations and leadership is limited, and its historical securities listing does not necessarily indicate that it remains an active operating business.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 61,200 shs
• Market Capitalization: $130 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 11/14/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:DNAG
• CIK: N/A
• Web: www.dnaprint.com
• Phone: (941) 366-3400
• Fax: 941-952-9770
• Employees: 24
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,294,790,000
• Free Float: N/A
• Market Cap: $130 thousand
• Optionable: Not Optionable
• Beta: N/A